Rosa Capital Inc. Announces Closing of Initial Public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Rosa Capital Inc. Announces Closing of Initial Public Offering

CALGARY, ALBERTA--(Marketwired - April 17, 2013) - Rosa Capital Inc. ("Rosa" or the "Corporation") (TSX VENTURE:RSA.P) is pleased to announce that on April 16, 2013, it has successfully completed its initial public offering ("Offering"), raising gross proceeds of $1,500,000 pursuant to a prospectus dated January 28, 2013. An aggregate of 7,500,000 common shares in the capital of the Corporation (the "Shares") were subscribed for at a price of $0.20 per Share. The Corporation has received conditional listing approval from the TSX Venture Exchange (the "Exchange") for its Shares and the shares are expected to commence trading on or about April 22, 2013 under the stock symbol RSA.P.

Integral Wealth Securities Limited (the "Agent") acted as the agent for the Offering. The Agent received a cash commission equal to 8% of the gross proceeds of the Offering and an option to purchase 750,000 Shares at a price of $0.20 per Share for a period of 24 months from the date of listing of the Shares on the Exchange. The Agent also received a corporate finance fee of $15,000.

Upon closing of the Offering, Rosa granted 875,000 incentive stock options to its directors and officers which are exercisable within five years from the date of the grant at an exercise price of $0.20 per Share. As a result of the closing of its initial public offering, Rosa now has 10,650,000 Shares issued and outstanding (3,150,000 of which are subject to escrow restrictions).

About the Corporation

Rosa is a capital pool company ("CPC") within the meaning of the policies of the Exchange that has not commenced commercial operations and has no assets other than cash. The board of directors of Rosa consists of Danny Geremia, Dennis Nerland, Gregory Peterson and Massimo Geremia. The officers of the Corporation are Tom Spoletini, Jason McCormick and Frank Sur. Except as specifically contemplated in the Exchange's CPC policy, until the completion of its Qualifying Transaction, the Corporation will not carry on business, other than the identification and evaluation of companies, business or assets with a view to completing a proposed Qualifying Transaction.

Forward Looking Information

This news release contains statements about Rosa's expectations regarding the completion of the application for listing, and the commencement of trading, on the Exchange that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as final listing approval from the Exchange. Although Rosa believes that the expectations reflected in these forward-looking statements are reasonable as Rosa assumes it will be able to fulfill the terms of the conditional listing approval granted by the Exchange, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include failure to fulfill conditions of listing and inability to obtain required regulatory approvals. The forward-looking statements contained in this news release are made as of the date hereof, and Rosa undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.

This news release does not constitute an offer to sell or a solicitation of any offer to buy the common shares in the United States. The common shares have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption for the registration requirements of such Act.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Rosa Capital Inc. Gregory Peterson Director (403) 292-9812 (403) 695-3522 (FAX)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 37

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 28

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 32

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 36

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 23

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 36

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Technologies Unveiled by LG Innotek at CES 2025

Updated Category News Views 383

Innovative Showcase by LG Innotek at CES 2025 LG Innotek has exciting plans for CES 2025, showcasing its commitment to revolutionizing future mobility. This year, the company aims to highlight its advanced technologies at a well-organized exhibition booth set within the bustling West Hall. A Focus on Future Mobility Technologies At CES 2025, LG Innotek will present a...

Continue Reading
Alumis and ACELYRIN Merger: A New Era for Biopharma Innovation

Updated Category News Views 277

Alumis and ACELYRIN Merge to Forge a New Path in Biopharma The biopharmaceutical landscape is about to witness a significant transformation as Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. (NASDAQ: SLRN) announce their merger. This strategic alliance aims to innovate, develop, and commercialize new therapies for immune-mediated diseases. With top-tier clinical programs...

Continue Reading
Legal Reminder for ICON Shareholders: Act Before Deadline

Updated Category News Views 147

Important Update for ICON plc Shareholders In a significant legal development, shareholders of ICON plc need to be aware of a class action lawsuit that has implications for their investments. If you have incurred losses exceeding $100,000, it is essential to act swiftly, as the deadline for filing lead plaintiff applications is approaching. This lawsuit originates from...

Continue Reading
Corvus Pharmaceuticals to Showcase Innovations at Investment Event

Updated Category News Views 50

Corvus Pharmaceuticals to Present at Major Investment Conference BURLINGAME, Calif. — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a prominent name in the clinical-stage biopharmaceutical sector, is thrilled to announce that its president and CEO, Richard A. Miller, M.D., along with Jeffrey Arcara, the chief business officer, will be participating in one-on-one meetings...

Continue Reading
Discover Promising Dividend Stocks with Robust Growth Potential

Updated Category News Views 122

Exploring Reliable Dividend Stocks with Growth Potential Investors have found that dividend stocks generally offer a compelling annual return averaging 9.2% since 1973, showing less volatility than the broader market index. These investments can provide a steady income stream while also having a significant upside potential. In this article, we delve into three stocks...

Continue Reading